BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,124 filers reported holding BAXTER INTL INC in Q2 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.3%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,835 | -20.7% | 1,135 | -4.2% | 0.00% | -33.3% |
| Q2 2023 | $53,989 | +12.3% | 1,185 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $48,064 | -20.4% | 1,185 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $60,399 | -5.6% | 1,185 | 0.0% | 0.00% | -40.0% |
| Q3 2022 | $64,000 | -15.8% | 1,185 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $76,000 | -17.4% | 1,185 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $92,000 | -9.8% | 1,185 | 0.0% | 0.01% | -16.7% |
| Q4 2021 | $102,000 | -99.9% | 1,185 | -6.8% | 0.01% | 0.0% |
| Q3 2021 | $102,219,000 | -0.1% | 1,271 | 0.0% | 0.01% | 0.0% |
| Q2 2021 | $102,308,000 | -4.6% | 1,271 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $107,188,000 | +104986.3% | 1,271 | 0.0% | 0.01% | 0.0% |
| Q4 2020 | $102,000 | -99.9% | 1,271 | -4.3% | 0.01% | -57.1% |
| Q3 2020 | $106,767,000 | +4.5% | 1,328 | -29.5% | 0.01% | 0.0% |
| Q2 2020 | $102,131,000 | +6.2% | 1,885 | +59.1% | 0.01% | -17.6% |
| Q1 2020 | $96,210,000 | -3.8% | 1,185 | -0.9% | 0.02% | +30.8% |
| Q4 2019 | $100,010,000 | +96997.1% | 1,196 | +0.9% | 0.01% | -13.3% |
| Q3 2019 | $103,000 | -99.9% | 1,185 | -9.2% | 0.02% | -6.2% |
| Q2 2019 | $106,880,000 | +2.3% | 1,305 | +1.6% | 0.02% | -5.9% |
| Q1 2019 | $104,483,000 | +124284.5% | 1,285 | 0.0% | 0.02% | +6.2% |
| Q4 2018 | $84,000 | -15.2% | 1,285 | 0.0% | 0.02% | -15.8% |
| Q3 2018 | $99,000 | -58.6% | 1,285 | -62.5% | 0.02% | -90.4% |
| Q2 2015 | $239,000 | +2.1% | 3,425 | 0.0% | 0.20% | +2.6% |
| Q1 2015 | $234,000 | -6.8% | 3,425 | 0.0% | 0.19% | -13.8% |
| Q4 2014 | $251,000 | – | 3,425 | – | 0.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
| SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
| Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
| Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
| HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
| Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
| 13D Management LLC | 200,318 | $14,791,000 | 3.77% |
| ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
| Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |